RAPT Therapeutics (NASDAQ:RAPT) shares are down 7.6% after-hours after the firm has priced its previously announced underwritten public offering of 4,054,055 shares of its common stock at a price to the public of $18.50/share.
All of the shares of common stock are being offered by RAPT.
Gross proceeds to RAPT from the offering are expected to be $75M.
Underwriters are granted a 30-day option to purchase up to an additional 608,108 shares of common stock at the public offering price.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Offering is expected to close on November 22, 2022.
Now Read: RAPT Therapeutics announces $75M stock offering
Source: <span style=”color: #000000″><a style=”color: #000000″ href=”https://seekingalpha.com/news/3909524-rapt-therapeutics-stock-slide-on-pricing-75m-stock-offering” target=”_blank” rel=”noopener noreferrer”>Seeking Alpha</a></span>
